Marlowe’s (MRL) Outperform Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Marlowe (LON:MRL) in a research report released on Thursday morning, Marketbeat reports. Royal Bank of Canada currently has a GBX 690 ($8.88) target price on the stock.

Separately, Berenberg Bank lowered their price objective on Marlowe from GBX 720 ($9.26) to GBX 710 ($9.13) and set a buy rating on the stock in a research note on Tuesday, April 30th.

Marlowe Price Performance

Marlowe stock opened at GBX 432 ($5.56) on Thursday. The stock’s fifty day moving average price is GBX 480.44 and its two-hundred day moving average price is GBX 478.44. Marlowe has a one year low of GBX 310 ($3.99) and a one year high of GBX 620 ($7.98). The company has a debt-to-equity ratio of 58.34, a current ratio of 1.29 and a quick ratio of 0.80. The firm has a market cap of £418.44 million, a PE ratio of -2,880.00 and a beta of 0.42.

Marlowe Announces Dividend

The firm also recently announced a dividend, which was paid on Friday, July 5th. Shareholders of record on Thursday, June 13th were issued a GBX 155 ($1.99) dividend. This represents a dividend yield of 27.78%. The ex-dividend date of this dividend was Thursday, June 13th.

Insider Buying and Selling at Marlowe

In other Marlowe news, insider Lord Ashcroft bought 3,422,809 shares of Marlowe stock in a transaction on Wednesday, May 22nd. The shares were purchased at an average price of GBX 548 ($7.05) per share, with a total value of £18,756,993.32 ($24,127,853.51). Company insiders own 23.17% of the company’s stock.

Marlowe Company Profile

Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.